New diabetes clinical trial: A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India

Published on: December 21, 2022 at 11:00AM
Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: Dulaglutide
Sponsor:   Eli Lilly and Company
Not yet recruiting
https://ift.tt/ha4n8YP